Polarean Imaging Plc Equity Research & Stock Reports | Research Tree
Polarean Imaging Plc recibe el primer pedido de novo de un nuevo polarizador XENOVIEWtm -07 de diciembre 2023 a las 08:00 | MarketScreener
Polarean hits another key milestone with University of Missouri upgrade | AIM:POLX, OTC:PLLWF
Polarean (@PolareanImaging) / X
Polarean, Inc. | Xenon 129 MRI
Polarean on X: "Polarean Imaging #POLX , announces its submission of a New Drug Application (NDA) and request for priority review to the US FDA for #hyperpolarized #Xenon gas used to evaluate
Polarean Imaging partners up to enhance potential of Xenon 129 MRI technology | AIM:POLX, OTC:PLLWF
Polarean Xenon MRI Platform | Polarean .com
Polarean Imaging new CEO sets out new sales initiatives, extends cash runway | AIM:POLX, OTC:PLLWF
Polarean (@PolareanImaging) / X
POLAREAN IMAGING PLC - Interim results presentation - YouTube
Polarean | LinkedIn
Sistema de resonancia magnética de vanguardia incorpora imágenes de xenón hiperpolarizado para mejor evaluación de la ventilación pulmonar - RM - mobile.Medimaging.es
News and Press Releases | Polarean .com
FDA Approves Polarean's XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the evaluation of lung ventilation — Duke OTC
Polarean (@PolareanImaging) / X
Brandfetch | Polarean Logos & Brand Assets
Polarean, Inc. | Xenon 129 MRI
Polarean, Inc. | Durham NC
Polarean delivers key milestones in H1, extends cash runway to Q2 2024 - Vox Markets
Polarean joins forces with VIDA to accelerate adoption of advanced MRI technology - Vox Markets
Polarean Imaging plc - AnnualReports.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G2WXGSOW2NIANG4CK7HK6T3RLI.jpg "Polarean Imaging says FDA rejects new drug application, shares slump | Reuters")